Küçükgüzel, Şükriye GünizSenkardes, SevilKart, DidemBebek, BilgeGunduz, Miyase GozdeKucukguzel, S. GunizEczacılık Meslek Bilimleri Bölümü2025-01-112025-01-11202320739-11021538-025410.1080/07391102.2022.21217612-s2.0-85143801364https://doi.org/10.1080/07391102.2022.2121761https://hdl.handle.net/20.500.14627/88Gunduz, Miyase Gozde/0000-0002-2287-9509; Kart, Didem/0000-0001-7119-5763; senkardes, sevil/0000-0002-0523-459XIn this work, twenty hydrazide-hydrazone and 4-thiazolidinone derivatives were synthesized starting from m-cresol. Antimicrobial evaluation was carried out by microdilution method against Enterococcus faecalis and Staphylococcus aureus as Gram-positive bacteria and Escherichia coli and Pseudomonas aeruginosa as Gram-negative bacteria, and three pathogenic fungi Candida albicans, Candida parapsilosis and Candida krusei. Some compounds possessed considerable antimicrobial properties against the tested microorganisms, particularly against E. coli. 4-Thiazolidinones containing 3-methoxyphenyl and 3,5-dichlorophenyl moieties (4h and 4i) were found to be the most active derivatives with MICs of 2 mu g/mL against E. coli. N'-[(3,5-dichlorophenyl)methylidene]-2-(3-methylphenoxy)acetohydrazide (3i) also displayed antifungal activity against Candida krusei that was comparable to fluconazole. Calculated drug-likeness and ADMET parameters of the most active compounds confirmed their potential as antimicrobial drug candidates. Molecular docking investigations were carried out in the thiamine diphosphate-binding site of pyruvate dehydrogenase multienzyme complex E1 component (PDHc-E1) to clarify the potential antibacterial mechanism against E. coli. The results showed the potential and importance of developing new hydrazones and 4-thiazolidinones that would be effective against microbial strains. Communicated by Ramaswamy H. Sarmaeninfo:eu-repo/semantics/openAccessCresolHydrazone4-ThiazolidinoneMolecular DockingAntimicrobial ActivitySynthesis, Antimicrobial Properties and <i>in Silico</I> Studies of Aryloxyacetic Acid Derivatives With Hydrazone or Thiazolidine-4 ScaffoldArticleQ1Q1411574217432WOS:00085423770000136102249